Abstract
Abstract Background: Overexpression of survivin is associated with resistance to radiotherapy and poor survival in many cancer types. However, in squamous cells carcinoma of head and neck (SCCHN), previous studies have revealed diverging results regarding survivin's role in clinical outcome. In this study, we aim to 1) evaluate the clinical significance of survivin expression in SCCHN; 2) identify the function of survivin on DNA damage repair following ionizing radiation (IR) in SCCHN cells; 3) investigate the potential of using honokiol, a nature compound, to enhance radiation therapy through down regulation of survivin. Methods: Protein expression of survivin in SCCHN patient primary tissues (n = 99) was analyzed by immunohistochemistry and correlated with clinical parameters. IR-sensitive (JHU-022), IR -insensitive (PCI-15A, Tu212), and IR acquired resistance (PCI-15A-R) SCCHN cell lines were used to evaluate the role of survivin in DNA double strain break repairer following RT. The in vitro effects of and potential molecular targets of honokiol were also evaluated using those cell lines. Results: Overexpression of survivin is significantly associated with lymph node metastasis, worse overall survival and worse disease free survival in patients receiving radiation therapy (n = 65) and in all patients with SCCHN (n = 99). In SCCHN cells, depletion of survivin by siRNA inhibited, whereas overexpression of survivin increased, clonogenic survival following IR. IR induces nuclear accumulation of survivin and complexation with γ-H2X, and DNA-PKCs, suggesting survivin is involved in DNA damage response and repair induced by IR. Further, honokiol significantly reduces survivin expression and increases DNA damage induced by IR, as demonstrated by higher amount of DNA breaks and an increased amount of γ-H2X foci post IR. Conclusions: Survivin is a negative prognostic factor in SCCHN, and is involved in DNA damage response and repair induced by IR in SCCHN cells. Down regulation of survivin by honokiol enhances the efficacy of IR, and may provide a novel therapeutic approach to improve the efficacy of radiotherapy in SCCHN. (This research was supported by the National Cancer Institute award P50 CA128613, and GCC Distinguished Cancer Scholar to Dong M. Shin, Zhuo (Georgia) Chen, and Jonathan J Beitler) Citation Format: Xu Wang, Jonathan J. Beitler, Wen Huang, Guoqing Qian, Kelly Magliocca, Jun Zhang, Sreenivas Nannapaneni, Sungjin Kim, Zhengjia Chen, Saba F. Nabil, Zhuo G. Chen, Jack L. Arbiser, Dong M. Shin. Honokiol radiosensitizes squamous cells carcinoma of head and neck by down-regulation of survivin. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 20. doi:10.1158/1538-7445.AM2015-20
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.